|
ES2427641T3
(es)
|
2003-05-22 |
2013-10-31 |
Ibio, Inc. |
Molécula vehículo recombinante para la expresión, el suministro y la purificación de polipéptidos diana
|
|
CN101378781B
(zh)
|
2005-08-03 |
2013-08-07 |
美国弗劳恩霍夫股份有限公司 |
制造免疫球蛋白的组合物和方法
|
|
JP5346820B2
(ja)
*
|
2007-03-13 |
2013-11-20 |
エイチユーエムエイビーエス・リミテッド・ライアビリティ・カンパニー |
Ｈ５ｎ１亜型ａ型インフルエンザウィルスに対する抗体
|
|
US8404252B2
(en)
|
2007-07-11 |
2013-03-26 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
|
CA2733218A1
(en)
|
2008-07-25 |
2010-01-28 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
US8734803B2
(en)
|
2008-09-28 |
2014-05-27 |
Ibio Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
|
GB0818356D0
(en)
*
|
2008-10-07 |
2008-11-12 |
Istituto Superiore Di Sanito |
Antibodies
|
|
DK2350128T3
(da)
|
2008-10-22 |
2014-12-01 |
Inst Research In Biomedicine |
Fremgangsmåder til fremstilling af antistoffer fra plasmaceller
|
|
MX2011011331A
(es)
*
|
2009-05-11 |
2011-11-18 |
Crucell Holland Bv |
Moleculas de union humanas capaces de neutralizar el virus de la influenza h3n2 y usos de las mismas.
|
|
EP2483307A1
(en)
|
2009-09-29 |
2012-08-08 |
Fraunhofer USA, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
|
WO2012021786A2
(en)
*
|
2010-08-12 |
2012-02-16 |
Theraclone Sciences, Inc. |
Anti-hemagglutinin antibody compositions and methods of use thereof
|
|
CN102775469B
(zh)
*
|
2011-05-12 |
2018-02-09 |
厦门大学 |
甲型流感病毒核衣壳蛋白的抗原表位及其用途
|
|
EP3418300B1
(en)
|
2011-07-18 |
2020-10-28 |
Institute for Research in Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
|
JP2013087069A
(ja)
*
|
2011-10-17 |
2013-05-13 |
Toyobo Co Ltd |
Ｈ５亜型インフルエンザウイルスを特異的に認識するモノクローナル抗体
|
|
EP2793945B1
(en)
|
2011-12-05 |
2018-08-15 |
Trellis Bioscience, LLC |
Antibodies useful in passive influenza immunization
|
|
US9233152B2
(en)
|
2012-01-12 |
2016-01-12 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies targeting neutralizing epitopes on H5 influenza virus of clade 2.3
|
|
US9969794B2
(en)
|
2012-05-10 |
2018-05-15 |
Visterra, Inc. |
HA binding agents
|
|
JP6386465B2
(ja)
|
2012-11-13 |
2018-09-05 |
ジェネンテック， インコーポレイテッド |
抗ヘマグルチニン抗体及び使用方法
|
|
JP6595448B2
(ja)
*
|
2013-03-14 |
2019-10-23 |
コントラフェクト コーポレイション |
治療効率の増強のために鼻腔内送達する中和抗体に基づく組成物および方法
|
|
PT3052192T
(pt)
|
2013-10-02 |
2020-09-24 |
Medimmune Llc |
Anticorpos neutralizantes anti-influenza a e suas utilizações
|
|
KR102344390B1
(ko)
|
2014-02-04 |
2021-12-28 |
콘트라펙트 코포레이션 |
수동 인플루엔자 면역화에 유용한 항체, 및 이의 사용을 위한 조성물, 조합 및 방법
|
|
US10639370B2
(en)
|
2014-02-04 |
2020-05-05 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
KR101628331B1
(ko)
*
|
2014-03-28 |
2016-06-08 |
주식회사 녹십자엠에스 |
인플루엔자 a 바이러스 특이적 단클론 항체 및 이를 이용한 인플루엔자 감염 치료 및 진단 방법
|
|
JP6614523B2
(ja)
*
|
2014-03-28 |
2019-12-04 |
地方独立行政法人神奈川県立産業技術総合研究所 |
インフルエンザウイルスのｒｎａ依存性ｒｎａポリメラーゼのｐｂ２サブユニットに対するモノクローナル抗体
|
|
CA2954780A1
(en)
|
2014-07-15 |
2016-01-21 |
Medimmune, Llc |
Neutralizing anti-influenza b antibodies and uses thereof
|
|
TWI702229B
(zh)
|
2014-12-19 |
2020-08-21 |
美商再生元醫藥公司 |
流行性感冒病毒血球凝集素之人類抗體
|
|
EA201792500A1
(ru)
|
2015-05-13 |
2018-04-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Aav-опосредованная экспрессия антител против гриппа и способы их использования
|
|
EP3960761A1
(en)
|
2015-06-01 |
2022-03-02 |
MedImmune, LLC |
Neutralizing anti-influenza binding molecules and uses thereof
|
|
EP3374390A1
(en)
|
2015-11-13 |
2018-09-19 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
|
IL304940A
(en)
|
2016-01-13 |
2023-10-01 |
Medimmune Llc |
A method for treating type A influenza
|
|
EP3419663A1
(en)
|
2016-02-24 |
2019-01-02 |
Visterra, Inc. |
Formulations of antibody molecules to influenza virus
|
|
PL238020B1
(pl)
*
|
2016-09-12 |
2021-06-28 |
Inst Biotechnologii I Antybiotykow |
Kompozycja przeciwciał monoklonalnych przeciwko hemaglutyninie wirusów grypy serotypu H5 i jej zastosowanie, hybrydomy produkujące rzeczone przeciwciała, sposób diagnozowania infekcji wirusami grypy serotypu H5 oraz zestawy diagnostyczne
|
|
BR112019017697A2
(pt)
|
2017-02-28 |
2020-04-07 |
The Trustees Of The University Of Pennsylvania |
vacinas contra influenza baseadas em vetores de vírus adenoassociado (aav)
|
|
MX2019010275A
(es)
|
2017-02-28 |
2019-10-15 |
Univ Pennsylvania |
Novedoso vector del subtipo f del virus adenoasociado (aav) y usos de este.
|
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
|
PE20242042A1
(es)
|
2017-06-02 |
2024-10-10 |
Pfizer |
Anticuerpos especificos para flt3 y sus usos
|
|
CA3132521A1
(en)
|
2019-03-25 |
2020-10-01 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
|
EP4087590A4
(en)
*
|
2020-01-12 |
2024-05-15 |
Vanderbilt University |
HUMAN ANTIBODIES AGAINST CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS
|
|
WO2021202815A1
(en)
*
|
2020-03-31 |
2021-10-07 |
Northeastern University |
Colorimetric and multiplexed isothermal rna-and antibody-based assay for sars-cov-2 and other viral diagnostics and cell analysis
|
|
CN114181302B
(zh)
*
|
2020-09-14 |
2023-03-24 |
东莞市朋志生物科技有限公司 |
针对甲型流感病毒的抗体、试剂盒和载体
|
|
US12319747B2
(en)
|
2023-07-03 |
2025-06-03 |
Medicovestor, Inc. |
Methods of using anti-SP17 immunotherapeutics
|
|
US12624097B2
(en)
|
2023-07-03 |
2026-05-12 |
Medicovestor, Inc. |
Nucleic acids, vectors, and cells that encode anti-Sp17 antibodies and other Sp17 binding proteins
|
|
US12364777B2
(en)
|
2023-10-20 |
2025-07-22 |
Medicovestor, Inc. |
Homodimeric antibodies for use in treating cancers and methods of use
|
|
US12121587B1
(en)
|
2023-12-26 |
2024-10-22 |
Medicovestor, Inc. |
Dimeric antibodies
|
|
US12116410B1
(en)
|
2023-12-26 |
2024-10-15 |
Medicovestor, Inc. |
Methods of manufacturing dimeric antibodies
|
|
US12600795B2
(en)
|
2023-12-26 |
2026-04-14 |
Medicovestor, Inc. |
Oligomeric IgG for immunotherapeutics and diagnostics
|
|
WO2025245380A1
(en)
*
|
2024-05-22 |
2025-11-27 |
Vanderbilt University |
Antibody generation
|